Amy Pickar Abernethy

991 total citations
55 papers, 402 citations indexed

About

Amy Pickar Abernethy is a scholar working on Oncology, Economics and Econometrics and Cancer Research. According to data from OpenAlex, Amy Pickar Abernethy has authored 55 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Economics and Econometrics and 15 papers in Cancer Research. Recurrent topics in Amy Pickar Abernethy's work include Economic and Financial Impacts of Cancer (17 papers), Palliative Care and End-of-Life Issues (10 papers) and Cancer Genomics and Diagnostics (8 papers). Amy Pickar Abernethy is often cited by papers focused on Economic and Financial Impacts of Cancer (17 papers), Palliative Care and End-of-Life Issues (10 papers) and Cancer Genomics and Diagnostics (8 papers). Amy Pickar Abernethy collaborates with scholars based in United States, Australia and United Kingdom. Amy Pickar Abernethy's co-authors include Ann M. Berger, Barbara A. Murphy, William F. Pirl, Charles S. Cleeland, Jennifer A. Ligibel, Eve T. Rodler, Carmen P. Escalante, James Thomas, Lynne I. Wagner and David Cella and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Palliative Medicine and Journal of the National Comprehensive Cancer Network.

In The Last Decade

Amy Pickar Abernethy

51 papers receiving 392 citations

Peers

Amy Pickar Abernethy

ONCOL

PPCH

PRM

PHEOH

PHYSI

Julia Hamer Canada

Mauro Guglielmo Italy

Pleun J. de Raaf Netherlands

Katherine Sharpe United States

Sabine Taubenheim Germany

Lisa Massie United States

Tania Lobo United States

Ju‐Whei Lee United States

Agnès Dumas France

Heidi Penttinen Finland

Julia Hamer Canada

Amy Pickar Abernethy

254 ×1.0

ONCOL

69 ×0.5

PPCH

92 ×0.9

PRM

67 ×0.8

PHEOH

54 ×1.3

PHYSI

Citations per year, relative to Amy Pickar Abernethy Amy Pickar Abernethy (= 1×) peers Julia Hamer

Countries citing papers authored by Amy Pickar Abernethy

Since Specialization

Citations

This map shows the geographic impact of Amy Pickar Abernethy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Pickar Abernethy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Pickar Abernethy more than expected).

Fields of papers citing papers by Amy Pickar Abernethy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Pickar Abernethy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Pickar Abernethy. The network helps show where Amy Pickar Abernethy may publish in the future.

Co-authorship network of co-authors of Amy Pickar Abernethy

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Pickar Abernethy. A scholar is included among the top collaborators of Amy Pickar Abernethy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Pickar Abernethy. Amy Pickar Abernethy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agarwala, Vineeta, Anala Gossai, Gaurav Singal, et al.. (2018). Use of cancer immunotherapies in the real-world in the setting of microsatellite instability.. Journal of Clinical Oncology. 36(5_suppl). 30–30.

Wolf, Steven, et al.. (2018). The Surprise Question and Identification of Palliative Care Needs among Hospitalized Patients with Advanced Hematologic or Solid Malignancies. Journal of Palliative Medicine. 21(6). 789–795. 27 indexed citations

O’Connor, Jeremy, Kathi Seidl-Rathkopf, Paul You, et al.. (2017). Adoption of immunotherapy into real-world practice: Insights from the use of checkpoint inhibitors.. Journal of Clinical Oncology. 35(15_suppl). e14583–e14583. 2 indexed citations

O’Connor, Jeremy, Kathi Seidl-Rathkopf, Aracelis Z. Torres, et al.. (2017). Racial disparities in the use of programmed death-1 checkpoint inhibitors.. Journal of Clinical Oncology. 35(15_suppl). 3068–3068. 2 indexed citations

Currow, David C., Jennifer S. Temel, Amy Pickar Abernethy, et al.. (2016). Efficacy of anamorelin in cachectic patients with non-small cell lung cancer (NSCLC) and low BMI (< 20 kg/m²): Post-hoc analysis of two phase III studies.. Journal of Clinical Oncology. 34(26_suppl). 203–203. 1 indexed citations

Temel, Jennifer S., David C. Currow, Kenneth C. H. Fearon, et al.. (2015). Phase III trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachexia (ROMANA 1 and 2).. Journal of Clinical Oncology. 33(15_suppl). 9500–9500. 6 indexed citations

Long, Georgina V., Victoria Atkinson, Paolo A. Ascierto, et al.. (2015). Effect of nivolumab (NIVO) on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): Results of a phase III study (CheckMate 066).. Journal of Clinical Oncology. 33(15_suppl). 9027–9027. 3 indexed citations

Bickel, Kathleen, Kristen K. McNiff, Mary K. Buss, et al.. (2015). Defining high-quality palliative care in oncology practice: An ASCO/AAHPM Guidance Statement.. Journal of Clinical Oncology. 33(29_suppl). 108–108. 2 indexed citations

Abernethy, Amy Pickar, Michael A. Postow, Jason Chesney, et al.. (2015). Effect of nivolumab (NIVO) in combination with ipilimumab (IPI) versus IPI alone on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): Results of a phase II study (CheckMate 069).. Journal of Clinical Oncology. 33(15_suppl). 9029–9029. 7 indexed citations

10.

Currow, David C., Jennifer S. Temel, Kenneth C. H. Fearon, et al.. (2015). A safety extension study of anamorelin in advanced non-small cell lung cancer patients with cachexia: ROMANA 3.. Journal of Clinical Oncology. 33(15_suppl). e20715–e20715. 5 indexed citations

11.

LeBlanc, Thomas W., Steven Wolf, Greg Samsa, et al.. (2015). Symptom burden, quality of life, and distress in acute myeloid leukemia patients receiving induction chemotherapy: A prospective electronic patient-reported outcomes study.. Journal of Clinical Oncology. 33(15_suppl). e20702–e20702. 1 indexed citations

12.

LeBlanc, Thomas W., Cristina Gasparetto, Sascha A. Tuchman, et al.. (2014). Exploring variations in multiple myeloma management through in-practice research.. Journal of Clinical Oncology. 32(15_suppl). e19534–e19534. 1 indexed citations

13.

Nipp, Ryan David, Leah L. Zullig, Gregory P. Samsa, et al.. (2014). Coping with cancer treatment-related financial burden.. Journal of Clinical Oncology. 32(31_suppl). 161–161. 2 indexed citations

14.

Abernethy, Amy Pickar, David C. Currow, Kenneth Fearon, et al.. (2014). Anamorelin for the treatment of cancer anorexia-cachexia: Baseline characteristics from three phase III clinical trials (the ROMANA program).. Journal of Clinical Oncology. 32(15_suppl). e20694–e20694. 1 indexed citations

15.

Kamal, Arif H., Janet Bull, Steven Wolf, et al.. (2014). Prevalence and predictors of burnout among specialty palliative care clinicians in the United States: Results of a national survey.. Journal of Clinical Oncology. 32(31_suppl). 87–87. 2 indexed citations

16.

Kamal, Arif H., Jonathan Nicolla, Keith M. Swetz, et al.. (2014). Formation of an international quality improvement collaborative for palliative care: The Global Palliative Care Quality Alliance (GPCQA).. Journal of Clinical Oncology. 32(31_suppl). 91–91. 1 indexed citations

17.

Abernethy, Amy Pickar, Ryan David Nipp, David C. Currow, et al.. (2013). Best supportive care (BSC) in published clinical trials.. Journal of Clinical Oncology. 31(15_suppl). 9560–9560. 1 indexed citations

18.

Mitchell, Aaron Philip, Steven K. Cheng, Asba Tasneem, et al.. (2012). Improving the impact of clinical research: A systematic analysis of kidney cancer trials.. Journal of Clinical Oncology. 30(15_suppl). 6051–6051. 1 indexed citations

19.

Zullig, Leah L., Doug Johnson, Olola Oneko, et al.. (2012). Assessment of cancer registries (CR) in low- and middle-income countries (LMCs).. Journal of Clinical Oncology. 30(15_suppl). 6102–6102. 1 indexed citations

20.

Berger, Ann M., Amy Pickar Abernethy, Andrea M. Barsevick, et al.. (2010). Cancer-Related Fatigue. Journal of the National Comprehensive Cancer Network. 8(8). 904–931. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact